Engineers Gate Manager’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Engineers Gate Manager’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,268	Closed	-$433K	–	2114
2023 Q1	$433K	Sell	32,268 -17,427	-35%	-$302K	0.02%	1049
2022 Q4	$615K	Sell	49,695 -695	-1%	-$9.84K	0.04%	771
2022 Q3	$703K	Buy	+50,390	New	+$811K	0.04%	605
2022 Q1	–	Sell	-12,520	Closed	-$204K	–	2438
2021 Q4	$204K	Sell	12,520 -6,093	-33%	-$103K	0.01%	1648
2021 Q3	$276K	Buy	18,613 +7,603	+69%	+$122K	0.02%	1243
2021 Q2	$220K	Sell	11,010 -7,600	-41%	-$151K	0.01%	1347
2021 Q1	$430K	Sell	18,610 -36,980	-67%	-$1.03M	0.02%	1083
2020 Q4	$1.37M	Buy	55,590 +16,020	+40%	+$531K	0.06%	462
2020 Q3	$1.64M	Buy	39,570 +8,795	+29%	+$404K	0.08%	378
2020 Q2	$1.47M	Buy	30,775 +7,476	+32%	+$578K	0.08%	416
2020 Q1	$1.47M	Buy	+23,299	New	+$2.09M	0.11%	270
2015 Q3	–	Sell	-1,125	Closed	-$272K	–	1020
2015 Q2	$272K	Buy	+1,125	New	+$300K	0.03%	831

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Engineers Gate Manager's ICPT Position: Q2 2023 in Review

Engineers Gate Manager sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 32,268 shares — an estimated $433K sold.

Engineers Gate Manager first reported a position in ICPT in Q2 2015 and held it in 12 quarters. The position peaked at $1.64M in Q3 2020. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Engineers Gate Manager reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Engineers Gate Manager sold 32,268 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $433K.
Engineers Gate Manager first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
Engineers Gate Manager's Intercept Pharmaceuticals, Inc. position peaked at $1.64M in Q3 2020.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Engineers Gate Manager's 13F filing for Q2 2023, filed 14 Aug 2023.